113 related articles for article (PubMed ID: 24724603)
1. Meningioma protein-protein interaction network.
Zali H; Rezaei Tavirani M
Arch Iran Med; 2014 Apr; 17(4):262-72. PubMed ID: 24724603
[TBL] [Abstract][Full Text] [Related]
2. Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas.
Aarhus M; Bruland O; Bredholt G; Lybaek H; Husebye ES; Krossnes BK; Vedeler C; Wester K; Lund-Johansen M; Knappskog PM
J Neurooncol; 2008 Jul; 88(3):251-9. PubMed ID: 18365142
[TBL] [Abstract][Full Text] [Related]
3. Meningioma transcription factors link cell lineage with systemic metabolic cues.
Du Z; Brewster R; Merrill PH; Chmielecki J; Francis J; Aizer A; Abedalthagafi M; Sholl LM; Geffers L; Alexander B; Santagata S
Neuro Oncol; 2018 Sep; 20(10):1331-1343. PubMed ID: 29660031
[TBL] [Abstract][Full Text] [Related]
4. Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence.
Bie L; Zhao G; Ju Y; Zhang B
Cancer Genet; 2011 Oct; 204(10):536-40. PubMed ID: 22137483
[TBL] [Abstract][Full Text] [Related]
5. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
6. The biological and diagnostic roles of MicroRNAs in meningiomas.
Wang L; Chen S; Liu Y; Zhang H; Ren N; Ma R; He Z
Rev Neurosci; 2020 Oct; 31(7):771-778. PubMed ID: 32697762
[TBL] [Abstract][Full Text] [Related]
7. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
8. Expression of survivin and p16(INK4a)/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells.
Al-Khalaf HH; Lach B; Allam A; Hassounah M; Alkhani A; Elkum N; Alrokayan SA; Aboussekhra A
Brain Res; 2008 Jan; 1188():25-34. PubMed ID: 18048012
[TBL] [Abstract][Full Text] [Related]
9. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
10. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomic profiles of meningioma subtypes.
Okamoto H; Li J; Vortmeyer AO; Jaffe H; Lee YS; Gläsker S; Sohn TS; Zeng W; Ikejiri B; Proescholdt MA; Mayer C; Weil RJ; Oldfield EH; Zhuang Z
Cancer Res; 2006 Oct; 66(20):10199-204. PubMed ID: 17047085
[TBL] [Abstract][Full Text] [Related]
12. Single-cell RNA sequencing identifies macrophage signatures correlated with clinical features and tumour microenvironment in meningiomas.
Zhang X
IET Syst Biol; 2023 Oct; 17(5):259-270. PubMed ID: 37515398
[TBL] [Abstract][Full Text] [Related]
13. Methylation markers of malignant potential in meningiomas.
Vengoechea J; Sloan AE; Chen Y; Guan X; Ostrom QT; Kerstetter A; Capella D; Cohen ML; Wolinsky Y; Devine K; Selman W; Barnett GH; Warnick RE; McPherson C; Chiocca EA; Elder JB; Barnholtz-Sloan JS
J Neurosurg; 2013 Oct; 119(4):899-906. PubMed ID: 23930849
[TBL] [Abstract][Full Text] [Related]
14. Meningioma transcript profiles reveal deregulated Notch signaling pathway.
Cuevas IC; Slocum AL; Jun P; Costello JF; Bollen AW; Riggins GJ; McDermott MW; Lal A
Cancer Res; 2005 Jun; 65(12):5070-5. PubMed ID: 15958550
[TBL] [Abstract][Full Text] [Related]
15. Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor.
Hankins GR; Sasaki T; Lieu AS; Saulle D; Karimi K; Li JZ; Helm GA
Neurosurgery; 2008 Oct; 63(4):771-80; discussion 780-1. PubMed ID: 18981889
[TBL] [Abstract][Full Text] [Related]
16. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.
Di Vinci A; Brigati C; Casciano I; Banelli B; Borzì L; Forlani A; Ravetti GL; Allemanni G; Melloni I; Zona G; Spaziante R; Merlo DF; Romani M
Transl Res; 2012 Nov; 160(5):355-62. PubMed ID: 22735029
[TBL] [Abstract][Full Text] [Related]
17. Bcl2 and ROS1 expression in human meningiomas: an analysis with respect to histological subtype.
Girish V; Sachdeva N; Minz RW; Radotra B; Mathuria SN; Arora SK
Indian J Pathol Microbiol; 2005 Jul; 48(3):325-30. PubMed ID: 16761743
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology of brain meningiomas.
Byvalsev VA; Stepanov IA; Belykh EG; Yarullina AI
Patol Fiziol Eksp Ter; 2017; 61(2):82-91. PubMed ID: 29215848
[TBL] [Abstract][Full Text] [Related]
19. AKT1E17K mutations cluster with meningothelial and transitional meningiomas and can be detected by SFRP1 immunohistochemistry.
Sahm F; Bissel J; Koelsche C; Schweizer L; Capper D; Reuss D; Böhmer K; Lass U; Göck T; Kalis K; Meyer J; Habel A; Brehmer S; Mittelbronn M; Jones DT; Schittenhelm J; Urbschat S; Ketter R; Heim S; Mawrin C; Hainfellner JA; Berghoff AS; Preusser M; Becker A; Herold-Mende C; Unterberg A; Hartmann C; Kickingereder P; Collins VP; Pfister SM; von Deimling A
Acta Neuropathol; 2013 Nov; 126(5):757-62. PubMed ID: 24096618
[TBL] [Abstract][Full Text] [Related]
20. Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.
Saydam O; Senol O; Schaaij-Visser TB; Pham TV; Piersma SR; Stemmer-Rachamimov AO; Wurdinger T; Peerdeman SM; Jimenez CR
J Proteome Res; 2010 Jan; 9(1):485-94. PubMed ID: 19877719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
